The Expression Levels of MicroRNA-361-5p and Its Target VEGFA Are Inversely Correlated in Human Cutaneous Squamous Cell Carcinoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kanitz, Alexander ^a   Imig, Jochen ^a   Dziunycz, Piotr J ^b   Primorac, Adriana ^a   Galgano, Alessia ^a,c   Hofbauer, Günther F L ^b   Gerber, André P ^a,d   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 361 5P; UNCLASSIFIED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR RECOGNITION; PROMOTER REGION; PROTEIN FUNCTION; SKIN CARCINOMA;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HUMANS; MICRORNAS; MUTATION; SKIN; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84869120615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049568     Document Type: Article

References (101)

1. Detmar M, (2000) The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 24Suppl 1: S78-84.
2. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
3. Lohmann CM, Solomon AR, (2001) Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 8: 27-36.
4. Hofbauer GFL, Bouwes Bavinck JN, Euvrard S, (2010) Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 19: 473-482.
5. Schwartz RA, Bridges TM, Butani AK, Ehrlich A, (2008) Actinic keratosis: an occupational and environmental disorder. J Eur Acad Dermatol Venereol 22: 606-615.
6. Folkman J, (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6.
7. Ferrara N, Gerber H-P, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
8. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, et al. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580.
9. Bowden J, Brennan PA, Umar T, Cronin A, (2002) Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol 29: 585-589.
10. Detmar M, Velasco P, Richard L, Claffey KP, Streit M, et al. (2000) Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol 156: 159-167.
11. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, et al. (1999) Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5: 775-782.
12. Salven P, Heikkilä P, Joensuu H, (1997) Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 76: 930-934.
13. Tóth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N, (2000) Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol 31: 955-960.
14. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, et al. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108: 263-268.
15. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, et al. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180: 1141-1146.
16. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, et al. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607-12613.
17. Miquerol L, Langille BL, Nagy A, (2000) Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127: 3941-3946.
18. Harper SJ, Bates DO, (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8: 880-887.
19. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, et al. (1998) Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9: 469-481.
20. Levy NS, Goldberg MA, Levy AP, (1997) Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophy Acta 1352: 167-173.
21. Levy NS, Chung S, Furneaux H, Levy AP, (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423.
22. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, et al. (1999) Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 10: 907-919.
23. Shih SC, Claffey KP, (1999) Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem. 274: 1359-1365.
24. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, et al. (2004) Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23: 8673-8680.
25. Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, et al. (2004) A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur Journal Biochem 271: 648-660.
26. Onesto C, Berra E, Grépin R, Pagès G, (2004) Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA. J Biol Chem 279: 34217-34226.
27. Ray PS, Fox PL, (2007) A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. EMBO J 26: 3360-3372.
28. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP, (2008) Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol 28: 772-783.
29. Ray PS, Jia J, Yao P, Majumder M, Hatzoglou M, et al. (2009) A stress-responsive RNA switch regulates VEGFA expression. Nature 457: 915-919.
30. Jafarifar F, Yao P, Eswarappa SM, Fox PL, (2011) Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30: 1324-1334.
31. Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, et al. (2011) HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br J Cancer 104: 819-829.
32. Colombrita C, Onesto E, Megiorni F, Pizzuti A, Baralle FE, et al. (2012) TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem 287: 15635-15647.
33. Xin H, Brown J a, Gong C, Fan H, Brewer G, et al. (2012) Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA. Mol Cancer Res 10: 108-120.
34. Zhou S, Gu L, He J, Zhang H, Zhou M, (2011) MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia. Mol Cell Biol 31: 4928-4937.
35. Hua Z, Lv Q, Ye W, Wong C-KA, Cai G, et al. (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116.
36. Ye W, Lv Q, Wong C-KA, Hu S, Fu C, et al. (2008) The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One 3: e1719.
37. Huez I, Bornes S, Bresson D, Créancier L, Prats H, (2001) New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 15: 2197-2210.
38. Karaa ZS, Iacovoni JS, Bastide A, Lacazette E, Touriol C, et al. (2009) The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. RNA 15: 249-254.
39. Chamorro-Jorganes A, Araldi E, Penalva LOF, Sandhu D, Fernández-Hernando C, et al. (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31: 2595-2606.
40. Lei Z, Li B, Yang Z, Fang H, Zhang G-M, et al. (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4: e7629.
41. Liu B, Peng X-C, Zheng X-L, Wang J, Qin Y-W, (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66: 169-175.
42. Wu H, Zhu S, Mo Y-Y, (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19: 439-448.
43. Zhu N, Zhang D, Xie H, Zhou Z, Chen H, et al. (2011) Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 351: 157-164.
44. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, et al. (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107: 700-706.
45. Szczyrba J, Nolte E, Hart M, Döll C, Wach S, et al. (2012) Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. Int J Cancer. Epub ahead of print.
46. Yue X, Wang P, Xu J, Zhu Y, Sun G, et al. (2012) MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep 27: 1200-1206.
47. Chuang T-D, Panda H, Luo X, Chegini N, (2012) miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer 19: 541-556.
48. Panda H, Pelakh L, Chuang T-D, Luo X, Bukulmez O, et al. (2012) Endometrial miR-200c is Altered During Transformation into Cancerous States and Targets the Expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci 19: 786-796.
49. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S, (2011) MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 60: 1314-1323.
50. Long J, Wang Y, Wang W, Chang BHJ, Danesh FR, (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285: 23457-23465.
51. Li P, Guo W, Du L, Zhao J, Wang Y, et al. (2013) MicroRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin Sci (Lond) 124: 27-40.
52. Choi Y-C, Yoon S, Jeong Y, Yoon J, Baek K, (2011) Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells 32: 77-82.
53. Gaidatzis D, van Nimwegen E, Hausser J, Zavolan M, Nimwegen V, et al. (2007) Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics 8: 69.
54. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11: R90.
55. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
56. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-6.
57. Wang X, (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017.
58. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-8.
59. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R, (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517.
60. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
61. Afanasyeva EA, Hotz-Wagenblatt A, Glatting K-H, Westermann F, (2008) New miRNAs cloned from neuroblastoma. BMC Genomics 9: 52.
62. Blower PE, Verducci JS, Lin S, Zhou J, Chung J-H, et al. (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491.
63. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
64. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, et al. (2008) MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 26: 2496-2505.
65. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, et al. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83: 3333-3341.
66. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, et al. (2010) mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther 9: 1080-1091.
67. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 5: e9685.
68. Li Z-Y, Na H-M, Peng G, Pu J, Liu P, (2011) Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts. Mol Biosyst 7: 871-877.
69. Xie T, Liang J, Guo R, Liu N, Noble PW, et al. (2011) Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43: 479-487.
70. Keene JD, (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8: 533-543.
71. Kanitz A, Gerber AP, (2010) Circuitry of mRNA regulation. Wiley Interdiscip Rev Syst Biol Med 2: 245-251.
72. van Kouwenhove M, Kedde M, Agami R, (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656.
73. Imig J, Kanitz A, Gerber AP (2012) RNA regulons and the RNA-protein interaction network. Biomol Concepts. Epub ahead of print.
74. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
75. Liang Y, Li X-Y, Rebar EJ, Li P, Zhou Y, et al. (2002) Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility. J Biol Chem 277: 20087-20094.
76. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, et al. (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423.
77. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
78. Hirakawa S, Hong Y-K, Harvey N, Schacht V, Matsuda K, et al. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162: 575-586.
79. Kajiya K, Hirakawa S, Ma B, Drinnenberg I, Detmar M, (2005) Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 24: 2885-2895.
80. Winter J, Jung S, Keller S, Gregory RI, Diederichs S, (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228-234.
81. Baek D, Villén J, Shin C, Camargo FDFD, Gygi SPSP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
82. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
83. Galgano A, Forrer M, Jaskiewicz L, Kanitz A, Zavolan M, et al. (2008) Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system. PLoS One 3: e3164.
84. Sandberg R, Neilson JR, Sarma A, Sharp P a, Burge CB, (2008) Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320: 1643-1647.
85. Dibbens JA, Polyak SW, Damert A, Risau W, Vadas M, et al. (2001) Nucleotide sequence of the mouse VEGF 3′UTR and quantitative analysis of sites of polyadenylation. Biochim Biophy Acta 1518: 57-62.
86. Dziunycz P, Iotzova-Weiss G, Eloranta JJ, Läuchli S, Hafner J, et al. (2010) Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J Invest Dermatol 130: 2686-2689.
87. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, et al. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105: 44-50.
88. Cameron JD, Fine BS, Shapiro I, (1987) Histopathologic observations in choroideremia with emphasis on vascular changes of the uveal tract. Ophthalmology 94: 187-196.
89. Strunnikova N, Zein WM, Silvin C, MacDonald IM, (2012) Serum biomarkers and trafficking defects in peripheral tissues reflect the severity of retinopathy in three brothers affected by choroideremia. Adv Exp Med Biol 723: 381-387.
90. Meola N, Gennarino VA, Banfi S, (2009) microRNAs and genetic diseases. Pathogenetics 2: 7.
91. Guo X, Su B, Zhou Z, Sha J, (2009) Rapid evolution of mammalian X-linked testis microRNAs. BMC Genomics 10: 97.
92. Pinheiro I, Dejager L, Libert C, (2011) X-chromosome-located microRNAs in immunity: might they explain male/female differences? The × chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays 33: 791-802.
93. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
94. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
95. Detmar M, Tenorio S, Hettmannsperger U, Ruszczak Z, Orfanos CE, (1992) Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 98: 147-153.
96. Gebäck T, Schulz MMP, Koumoutsakos P, Detmar M, (2009) TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46: 265-274.
97. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-7.
98. Huang DW, Sherman BT, Stephens R, Baseler MW, Lane HC, et al. (2008) DAVID gene ID conversion tool. Bioinformation 2: 428-430.
99. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34: W645-50.
100. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M, (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-60.
101. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-82.